Phathom Pharmaceuticals, Inc. (PHAT)
10.74
-0.32
(-2.89%)
USD |
NASDAQ |
Mar 05, 16:00
10.72
-0.02
(-0.14%)
After-Hours: 20:00
Phathom Pharmaceuticals Cash from Investing (Quarterly) : -0.087M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| MannKind Corp. | -291.96M |
| Vanda Pharmaceuticals, Inc. | 44.87M |
| Ligand Pharmaceuticals, Inc. | -18.10M |
| Ocugen, Inc. | -0.035M |
| Rhythm Pharmaceuticals, Inc. | 30.35M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.001M |
| Cash from Financing (Quarterly) | -0.097M |
| Free Cash Flow | -167.00M |
| Free Cash Flow Per Share (Quarterly) | -0.0689 |
| Free Cash Flow to Equity (Quarterly) | -11.12M |
| Free Cash Flow to Firm (Quarterly) | 11.33M |
| Free Cash Flow Yield | -21.33% |